Liuji Sheng

Functional And Molecular Imaging Key Laboratory Of Sichuan Province
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Contrast-Enhanced CT Features for Identifying Primary Origin and Differentiation Grade of Neuroendocrine Liver Metastases.

Contrast-Enhanced CT Features for Identifying Primary Origin and Differentiation Grade of Neuroendocrine Liver Metastases.

Journal: Neuroendocrinology

Published: April 13, 2026

MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study.

MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study.

Journal: Journal of hepatology

Published: December 09, 2025

Performance of Liver Imaging Reporting and Data System (LI-RADS) nonradiation treatment response algorithm version 2024 on magnetic resonance imaging for transarterial chemoembolization plus systemic therapy in hepatocellular carcinoma.

Performance of Liver Imaging Reporting and Data System (LI-RADS) nonradiation treatment response algorithm version 2024 on magnetic resonance imaging for transarterial chemoembolization plus systemic therapy in hepatocellular carcinoma.

Journal: Quantitative imaging in medicine and surgery

Published: June 06, 2025

Large Language Models for Diagnosing Focal Liver Lesions From CT/MRI Reports: A Comparative Study With Radiologists.

Large Language Models for Diagnosing Focal Liver Lesions From CT/MRI Reports: A Comparative Study With Radiologists.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 21, 2024

Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy.

Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy.

Journal: Journal of hepatocellular carcinoma

Published: October 23, 2024

Imaging-based prediction of early recurrence and neoadjuvant therapy outcomes for resectable beyond Milan HCC.

Imaging-based prediction of early recurrence and neoadjuvant therapy outcomes for resectable beyond Milan HCC.

Journal: European journal of radiology

Published: August 28, 2024

Machine Learning Combined with Radiomics Facilitating the Personal Treatment of Malignant Liver Tumors.

Machine Learning Combined with Radiomics Facilitating the Personal Treatment of Malignant Liver Tumors.

Journal: Biomedicines

Published: November 20, 2023

Amide proton transfer-weighted imaging of the abdomen: Current progress and future directions.

Amide proton transfer-weighted imaging of the abdomen: Current progress and future directions.

Journal: Magnetic resonance imaging

Published: October 17, 2023

The Era of Immunotherapy in Hepatocellular Carcinoma: The New Mission and Challenges of Magnetic Resonance Imaging.

The Era of Immunotherapy in Hepatocellular Carcinoma: The New Mission and Challenges of Magnetic Resonance Imaging.

Journal: Cancers

Published: August 05, 2023

Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.

Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.

Journal: European journal of radiology

Published: July 12, 2023

Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.

Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.

Journal: BMC cancer

Published: October 21, 2022

Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.

Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.

Journal: Frontiers in oncology

Published: July 13, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026